An analysis of 5 machine-learning algorithms identified predictors for moderate-to-severe cancer-related fatigue in patients with CRC undergoing chemotherapy.

Minimal residual disease (MRD)-guided retreatment with anti-CD20 antibodies effectively lowers MRD levels and delays clinical relapse in patients with high-risk chronic lymphocytic leukemia (CLL), ...

N. Gopalakrishna Iyer, MBBS, PhD, noting that the researchers were “quite surprised” by the overall survival achieved in the control arm, given the real-world setting of the trial.

Ultra-low-pass whole genome sequencing (ULP-WGS) of circulating tumor DNA appears to provide important prognostic information regarding patients with large B-cell lymphoma (LBCL), according to ...

HealthDay News — Many people with cancer get directly involved in prior authorization (PA), often facing substantial time burdens, according to a study presented at the 2025 American Society of ...

Researchers suggest that tailoring interventions to symptom clusters and chemotherapy course may be best management strategy.

For patients with intraductal carcinoma of the prostate (IDC-P), prostate-specific membrane antigen positron emission tomography (PSMA PET) may not show intraprostatic uptake — even in high-grade ...

“ur finding enables the safe discontinuation of follow-up after 6 years, leading to an improvement in quality of life and a reduction in health care system costs,” study researchers wrote.

We demonstrate that patients with luminal B tumors derive clinically meaningful benefits … from the addition of apalutamide to secondary radiotherapy,” Dr Daniel Spratt said, adding that these ...

Current smoking was the most important predictor for a detrimental effect of aspirin on cancer incidence, whereas CHIP was the most important predictor for a beneficial effect of aspirin,” researchers ...

Standardized evaluation protocol improved transfer, ECSL outcomes, and re-transfer to discharge for pediatric hematologic oncology patients.

In breast cancer patients with a high recurrence score, the 5-year disease-free rate was significantly higher for patients receiving taxanes with anthracycline and cyclophosphamide than for those ...